Canagliflozin Reduces the Risk of Kidney Failure in Patients with Type 2 Diabetes Mellitus and Nephropathy: The CREDENCE Randomized Trial
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.
Details